Review Article

Cancer Survivor’s History and Physical

Authors: Alejandra C. Fuentes, MD, Jonathan E. Lambird, MD, Thomas J. George, MD, Merry Jennifer Markham, MD

Abstract

The number of cancer survivors is estimated by 2022 to increase to almost 18 million, in part because of improvements in earlier detection and cancer therapies, leading to longer-term survival of cancer patients. This growing number of survivors has presented challenges to the healthcare community, one of which is the need to provide to the survivor a seamless transition from the oncologist to the primary care provider (PCP). A major national initiative is under way for oncologists to provide survivorship care plans to their patients and PCPs, with the aim of communicating a complete record of cancer treatment and guiding the PCP in the future care of these cancer survivors. In caring for cancer survivors, PCPs must be familiar with the long-term and late effects, both medical and psychosocial, that are associated with common cancer treatments as well as the oncologic diagnosis itself. This article provides a unique approach to the traditional history and physical of easing the transition to primary care after completing cancer therapy for the cancer survivor. The cancer survivor–focused history and physical provide the PCP with a familiar and efficient method to clinically evaluate cancer survivors that closes the gap in this important transition of care.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Bell K, Ristovski-Slijepcevic S. Cancer survivorship: why labels matter. J Clin Oncol 2013;31:409-411.
 
2. Hewitt M, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. Committee on Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press, 2005.
 
3. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2011, National Cancer Institute. http://seer.cancer.gov/statfacts/html/all.html. Accessed October 3, 2016.
 
4. De Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev 2013;22:561-570.
 
5. National Cancer Institute. A tough transition: cancer survivorship plans slow to take hold. https://www.cancer.gov/about-cancer/coping/research/survivorship-plans. Published June 26, 2012. Accessed October 3, 2016.
 
6. Merport A, Lemon SC, Nyambose J, et al. The use of cancer treatment summaries and care plans among Massachusetts physicians. Support Care Cancer 2012;20:1579-1583.
 
7. Birken SA, Deal AM, Mayer DK, et al. Determinants of survivorship care plan use in US cancer programs. J Cancer Educ 2014;29:720-727.
 
8. Salz T, Oeffinger KC, McCabe MS, et al. Survivorship care plans in research and practice. CA Cancer J Clin 2012;62:101-117.
 
9. Stricker CT, Jacobs LA, Risendal B, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv 2011;5:358-370.
 
10. Forsythe LP, Parry C, Alfano CM, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst 2013;105:1579-1587.
 
11. Dulko D, Pace CM, Dittus KL, et al. Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum 2013;40:575-580.
 
12. Shalom MM, Hahn EE, Casillas J, et al. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract 2011;7:314-318.
 
13. Ezendam NP, Nicolaije KA, Kruitwagen RF, et al. Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized control trial. J Cancer Surviv 2014;8:595-602.
 
14. Commission on Cancer. Cancer program standards 2012: ensuring patient-centered care, version 1.2.1. https://www.facs.org/~/media/files/quality%20programs/cancer/coc/programstandards2012.ashx. Accessed August 4, 2015.
 
15. Potosky AL, Han PK, Rowland J, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 2011;26:1403-1410.
 
16. Nekhlyudov L, Aziz NM, Lerro C, et al. Oncologists’ and primary care physicians’ awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 2014;10:e29-e36.
 
17. Colwell J. Caring for cancer survivors. http://www.acphospitalist.org/archives/2014/05/cancer_survivors.htm. Published 2014. Accessed October 4, 2016.
 
18. Ferrell BR, Winn R. Medical and nursing education and training opportunities to improve survivorship care. J Clin Oncol 2006;24:5142-5148.
 
19. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58:82-91.
 
20. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): survivorship. http://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf. Accessed August 4, 2015.
 
21. Ruddy KJ, Barton D, Loprinzi CL. Laying to rest psychostimulants for cancer-related fatigue? J Clin Oncol 2014;32:1865-1867.
 
22. Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012;35:2402-2411.
 
23. de Haas EC, Oosting SF, Lefrandt JD, et al. The metabolic syndrome in cancer survivors. Lancet Oncol 2010;11:193-203.
 
24. Ganz PA. Monitoring the physical health of cancer survivors: a survivorship-focused medical history. J Clin Oncol 2006;24:5105-5111.
 
25. Hawkins NA, Smith T, Zhao L, et al. Health-related behavior change after cancer: results of the American Cancer Society’ studies on cancer survivors (SCS). J Cancer Surviv 2010;4:20-32.
 
26. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006;24:5132-5137.
 
27. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62:30-67.
 
28. Blanchard CM, Courneya KS, Stein K. Cancer survivor’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’ SCS-II. J Clin Oncol 2008;26:2198-2204.
 
29. National Cancer Institute. Family caregivers in cancer: roles and challenges (PDQ)-health professional version. http://www.cancer.gov/about-cancer/coping/family-friends/family-caregivers-hp-pdq. Accessed August 4, 2015.
 
30. Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:961-965.
 
31. Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013;31:4465-4470.
 
32. US Preventive Services Task Force. Published recommendations. http://www.uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations. Accessed August 4, 2015.
 
33. Rubin LG, Levin MJ, Ljungman P. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58:309-318.
 
34. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-1238.